Nuveen Asset Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$12.4M Sell
153,802
-94,827
-38% -$7.64M ﹤0.01% 1484
2024
Q3
$19.9M Buy
248,629
+87,020
+54% +$6.97M 0.01% 1200
2024
Q2
$9.87M Buy
161,609
+17,696
+12% +$1.08M ﹤0.01% 1582
2024
Q1
$7.11M Buy
143,913
+2,117
+1% +$105K ﹤0.01% 1795
2023
Q4
$5.94M Buy
141,796
+40,704
+40% +$1.71M ﹤0.01% 1886
2023
Q3
$3.32M Buy
101,092
+5,571
+6% +$183K ﹤0.01% 2065
2023
Q2
$3.38M Buy
95,521
+24,275
+34% +$858K ﹤0.01% 2096
2023
Q1
$2.02M Sell
71,246
-210,130
-75% -$5.97M ﹤0.01% 2324
2022
Q4
$11.7M Buy
281,376
+30,464
+12% +$1.27M ﹤0.01% 1387
2022
Q3
$10.4M Buy
250,912
+75,521
+43% +$3.13M ﹤0.01% 1447
2022
Q2
$5.73M Buy
175,391
+159,410
+997% +$5.21M ﹤0.01% 1863
2022
Q1
$559K Buy
15,981
+5,009
+46% +$175K ﹤0.01% 2985
2021
Q4
$274K Buy
+10,972
New +$274K ﹤0.01% 3191